계명대학교 의학도서관 Repository

항암화학요법제 투여중인 암환자의 빈혈에 대한 Recombinant Human Erythropoietin(Eprex)의 임상 효과

Metadata Downloads
Author(s)
홍대식강윤구권기영김병국김선영김주항김준석김형준김훈교박희숙송정섭송홍석신동복오도연이상재이순남장정순정태준조경삼최용묵현명수
Keimyung Author(s)
Kwon, Ki YoungSong, Hong Suk
Department
Dept. of Internal Medicine (내과학)
Journal Title
Korean Journal of Biological Response Modifiers
Issued Date
1996
Volume
6
Issue
1
Keyword
Recombinant human erythropoietinAnemiaCancerChemotherapy
Abstract
Background: Patients with advanced cancer frequently experience clinically significant anemia, which is often exacerbated by myelosuppressive chemotherapy.
Method : In an effort to evaluate a possible role for recombinant human erythropoietin(rHuEPO)in anemic patients with cancer receiving chemotherapy, we studied 160 anemic cancer patients receiving cyclic combination chemotherapy in prospective multicenter, randomized, oepn labeled, phase III study.
Result : In the 90 patients analyzed to date, respond to rHuEPO therapy was assessed by measuring changes in hematocrit level, and transfusion requirements.
Conclusion : We conclude the rHuEPO is safe and effective for reversing anemia related to chemotherapy for cancer.
Alternative Title
Clinical Effects of Recombinant Human Erythropoietin(Eprex) in Anemic Patients with Cancer Receiving Chemotherapy
Keimyung Author(s)(Kor)
권기영
송홍석
Publisher
School of Medicine
Citation
홍대식 et al. (1996). 항암화학요법제 투여중인 암환자의 빈혈에 대한 Recombinant Human Erythropoietin(Eprex)의 임상 효과. Korean Journal of Biological Response Modifiers, 6(1), 111–122.
Type
Article
URI
https://kumel.medlib.dsmc.or.kr/handle/2015.oak/36342
Appears in Collections:
1. School of Medicine (의과대학) > Dept. of Internal Medicine (내과학)
Authorize & License
  • Authorize공개
  • EmbargoForever
Files in This Item:

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.